Literature DB >> 29779439

Descriptive Phenotype of Obsessive Compulsive Symptoms in Males With Duchenne Muscular Dystrophy.

Angela J Lee1, Edward T Buckingham2, Aaron J Kauer2, Katherine D Mathews3.   

Abstract

Increased rates of clinically significant internalizing disorders (obsessive compulsive disorder, anxiety, and depression) have been demonstrated in males with Duchenne muscular dystrophy, and a Duchenne muscular dystrophy neuropsychiatric syndrome has been suggested. Although symptoms of depression are widely recognized, some of the other internalizing symptoms are less frequently identified. Through a retrospective chart review of 107 males with Duchenne muscular dystrophy, we identified 15 patients with obsessive compulsive disorder spectrum symptoms; 11 of those also had anxiety symptoms. Many of these patients received selective serotonin reuptake inhibitor treatment, commonly noting improvement in symptoms. Here we describe the clinical features of several patients in detail to facilitate early recognition and consideration for treatment for patients with Duchenne muscular dystrophy and internalizing psychiatric symptoms. The results of this cohort showed a significantly increased rate of obsessive compulsive disorder spectrum symptoms (14%) compared to the general population.

Entities:  

Keywords:  Duchenne muscular dystrophy; OCD; SSRIs; anxiety; internalizing disorders

Mesh:

Year:  2018        PMID: 29779439      PMCID: PMC6027593          DOI: 10.1177/0883073818774439

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  43 in total

1.  Anxiety disorders in adolescents and psychosocial outcomes at age 30.

Authors:  Cecilia A Essau; Peter M Lewinsohn; Beatriz Olaya; John R Seeley
Journal:  J Affect Disord       Date:  2014-01-02       Impact factor: 4.839

2.  Evidence-based health policy--lessons from the Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

Review 3.  Assessment and treatment of anxiety disorders in children and adolescents.

Authors:  Anna M Wehry; Katja Beesdo-Baum; Meghann M Hennelly; Sucheta D Connolly; Jeffrey R Strawn
Journal:  Curr Psychiatry Rep       Date:  2015-07       Impact factor: 5.285

4.  Role of disease severity, illness perceptions, and mood on quality of life in muscle disease.

Authors:  Michael R Rose; Reza Sadjadi; John Weinman; Tayyaba Akhtar; Shree Pandya; John T Kissel; Carlayne E Jackson
Journal:  Muscle Nerve       Date:  2012-09       Impact factor: 3.217

5.  Prevalence of fatigue, pain, and affective disorders in adults with duchenne muscular dystrophy and their associations with quality of life.

Authors:  Robert F Pangalila; Geertrudis A van den Bos; Bart Bartels; Michael Bergen; Henk J Stam; Marij E Roebroeck
Journal:  Arch Phys Med Rehabil       Date:  2015-02-27       Impact factor: 3.966

6.  A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents.

Authors:  H L Leonard; S E Swedo; M C Lenane; D C Rettew; S D Hamburger; J J Bartko; J L Rapoport
Journal:  Arch Gen Psychiatry       Date:  1993-06

Review 7.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

8.  Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations.

Authors:  Valeria Ricotti; William P L Mandy; Mariacristina Scoto; Marika Pane; Nicolas Deconinck; Sonia Messina; Eugenio Mercuri; David H Skuse; Francesco Muntoni
Journal:  Dev Med Child Neurol       Date:  2015-09-14       Impact factor: 5.449

9.  Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database.

Authors:  Zaïda Koeks; Catherine L Bladen; David Salgado; Erik van Zwet; Oksana Pogoryelova; Grace McMacken; Soledad Monges; Maria E Foncuberta; Kyriaki Kekou; Konstantina Kosma; Hugh Dawkins; Leanne Lamont; Matthew I Bellgard; Anna J Roy; Teodora Chamova; Velina Guergueltcheva; Sophelia Chan; Lawrence Korngut; Craig Campbell; Yi Dai; Jen Wang; Nina Barišić; Petr Brabec; Jaana Lähdetie; Maggie C Walter; Olivia Schreiber-Katz; Veronika Karcagi; Marta Garami; Agnes Herczegfalvi; Venkatarman Viswanathan; Farhad Bayat; Filippo Buccella; Alessandra Ferlini; En Kimura; Janneke C van den Bergen; Miriam Rodrigues; Richard Roxburgh; Anna Lusakowska; Anna Kostera-Pruszczyk; Rosário Santos; Elena Neagu; Svetlana Artemieva; Vedrana Milic Rasic; Dina Vojinovic; Manuel Posada; Clemens Bloetzer; Andrea Klein; Jordi Díaz-Manera; Eduard Gallardo; A Ayşe Karaduman; Tunca Oznur; Haluk Topaloğlu; Rasha El Sherif; Angela Stringer; Andriy V Shatillo; Ann S Martin; Holly L Peay; Jan Kirschner; Kevin M Flanigan; Volker Straub; Kate Bushby; Christophe Béroud; Jan J Verschuuren; Hanns Lochmüller
Journal:  J Neuromuscul Dis       Date:  2017

10.  Early neurodevelopmental assessment in Duchenne muscular dystrophy.

Authors:  Marika Pane; Roberta Scalise; Angela Berardinelli; Grazia D'Angelo; Valeria Ricotti; Paolo Alfieri; Isabella Moroni; Louise Hartley; Maria Carmela Pera; Giovanni Baranello; Michela Catteruccia; Tiziana Casalino; Domenico M Romeo; Alessandra Graziano; Claudia Gandioli; Flaviana Bianco; Elena Stacy Mazzone; Maria Elena Lombardo; Mariacristina Scoto; Serena Sivo; Concetta Palermo; Francesca Gualandi; Maria Pia Sormani; Alessandra Ferlini; Enrico Bertini; Francesco Muntoni; Eugenio Mercuri
Journal:  Neuromuscul Disord       Date:  2013-03-25       Impact factor: 4.296

View more
  8 in total

1.  Health-Related Quality of Life and Emotional Distress Among Mothers of Sons With Muscular Dystrophy as Compared to Sex- and Age Group-Matched Controls.

Authors:  Jamie L Jackson; Christina X Korth; Carine E Leslie; Jennifer Cotto; May Ling Mah; Kan Hor; Linda Cripe; Samiah Al-Zaidy; Eric M Camino; Kathleen Church; Kelly J Lehman; Victoria Shay; Jerry R Mendell
Journal:  J Child Neurol       Date:  2020-10-09       Impact factor: 1.987

2.  Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting.

Authors:  Peng Zhang; Jian He; Fei Wang; Jing Gong; Lu Wang; Qian Wu; Wenjiong Li; Hongju Liu; Jing Wang; Kunshan Zhang; Mao Li; Xusheng Huang; Chuanqiang Pu; Ying Li; Fengjie Jiang; Fudi Wang; Junxia Min; Xiaoping Chen
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-03-18       Impact factor: 12.910

3.  Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmdmdx rat model.

Authors:  Dorian Caudal; Virginie François; Aude Lafoux; Mireille Ledevin; Ignacio Anegon; Caroline Le Guiner; Thibaut Larcher; Corinne Huchet
Journal:  PLoS One       Date:  2020-03-11       Impact factor: 3.240

4.  Inhibition of sphingolipid de novo synthesis counteracts muscular dystrophy.

Authors:  Pirkka-Pekka Laurila; Peiling Luan; Martin Wohlwend; Nadège Zanou; Barbara Crisol; Tanes Imamura de Lima; Ludger J E Goeminne; Hector Gallart-Ayala; Minho Shong; Julijana Ivanisevic; Nicolas Place; Johan Auwerx
Journal:  Sci Adv       Date:  2022-01-28       Impact factor: 14.136

Review 5.  Psychopharmacological Treatments for Mental Disorders in Patients with Neuromuscular Diseases: A Scoping Review.

Authors:  Chiara Brusa; Giulio Gadaleta; Rossella D'Alessandro; Guido Urbano; Martina Vacchetti; Chiara Davico; Benedetto Vitiello; Federica S Ricci; Tiziana E Mongini
Journal:  Brain Sci       Date:  2022-01-28

Review 6.  Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy.

Authors:  Michael Naidoo; Karen Anthony
Journal:  Mol Neurobiol       Date:  2019-12-13       Impact factor: 5.590

7.  RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing.

Authors:  Maria S Falzarano; Andrea Grilli; Silvia Zia; Mingyan Fang; Rachele Rossi; Francesca Gualandi; Paola Rimessi; Reem El Dani; Marina Fabris; Zhiyuan Lu; Wenyan Li; Tiziana Mongini; Federica Ricci; Elena Pegoraro; Luca Bello; Andrea Barp; Valeria A Sansone; Madhuri Hegde; Barbara Roda; Pierluigi Reschiglian; Silvio Bicciato; Rita Selvatici; Alessandra Ferlini
Journal:  HGG Adv       Date:  2021-08-24

8.  Specific Dystrophins Selectively Associate with Inhibitory and Excitatory Synapses of the Mouse Cerebellum and their Loss Alters Expression of P2X7 Purinoceptors and Pro-Inflammatory Mediators.

Authors:  Torquil Jackson; Mohsen Seifi; Dariusz C Górecki; Jerome D Swinny
Journal:  Cell Mol Neurobiol       Date:  2021-06-08       Impact factor: 4.231

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.